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Abstract Stimulation of the epidermal growth factor receptor
(EGFR) produces membrane ru¥es through the small G protein
Rac1; however, the signaling pathway from EGFR to Rac1 has
not yet been clari¢ed. Here, we show that autophosphorylation
of EGFR at tyrosine 992 is required for EGF-induced mem-
brane ru¥e formation in CHO cells. Signaling from the auto-
phosphorylated tyrosine 992 appears to be mediated by phos-
pholipase C (PLC) Q1. Furthermore, activation of Rac1 by EGF
is inhibited by a PLC inhibitor. These results, taken together,
suggest that autophosphorylation of EGFR at tyrosine 992 and
the subsequent PLCQ1 activation transduce the signal to Rac1
to induce membrane ru¥e formation.
/ 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Epidermal growth factor (EGF) speci¢cally binds to and
activates the EGF receptor (EGFR), resulting in stimulation
of cellular responses such as cell proliferation [1,2] and mem-
brane ru¥e formation [3^5], the latter of which is critical for
cell movement. Upon EGF stimulation, the activated EGFR
is autophosphorylated at speci¢c residues in its cytoplasmic
region [6,7]. Five tyrosine residues at positions 992, 1068,
1086, 1148, and 1173 are major autophosphorylation sites
[8^11]. Autophosphorylated tyrosine residues serve as binding
sites for docking proteins with Src homology 2 (SH2) and
phosphotyrosine-binding domains to transduce signals from
EGFR to downstream signaling pathways [12,13]. These pro-
teins include enzymes, such as Src, phospholipase CQ1
(PLCQ1), and phosphatidylinositol 3-kinase that are phos-
phorylated and thereby activated, and adapter molecules,
such as Shc, Grb2, and Nck that interact with and activate
downstream e¡ectors [12^14].
Interaction of Grb2 with the autophosphorylated tyrosine
1068 of EGFR through its SH2 domain triggers the sequential
activation of the small GTPase Ras and mitogen-activated
protein kinase cascade, which in turn promotes cell prolifer-
ation [15^17]. On the other hand, another small GTPase,
Rac1, is the key molecule in the signaling pathway of EGF-
dependent membrane ru¥e formation [18]. We have recently
reported that phosphatidylinositol 4-phosphate [PI(4)P] 5-ki-
nase, which produces the versatile phospholipid phosphatidyl-
inositol 4,5-bisphosphate [PI(4,5)P2] by phosphorylation of
PI(4)P at the D5P position, is directly activated by ADP-ribo-
sylation factor (ARF) and that the ARF-dependent PI(4)P
5-kinase activation functions as a downstream signaling path-
way of Rac1 in membrane ru¥e formation [19]. Although,
thus, the signaling pathway downstream of Rac1 in EGF-in-
duced membrane ru¥e formation becomes clearer, the molec-
ular mechanism of signal transduction from EGFR to Rac1
remains to be elucidated.
In the present study, we ¢rst investigated which tyrosine
residue of EGFR, of ¢ve major autophosphorylation sites,
is required for EGF-induced membrane ru¥e formation,
and then examined which protein(s) or enzyme(s) play a
role as a docking molecule for the autophosphorylated
EGFR in membrane ru¥e formation. The results obtained
suggest that the autophosphorylation of EGFR at tyrosine
992 is required for EGF-induced membrane ru¥e formation
and that the docking enzyme PLCQ1 mediates the signaling
from the autophosphorylated EGFR to Rac1.
2. Materials and methods
2.1. Plasmids and antibodies
cDNAs for wild-type EGFR (WT-EGFR) and its mutants, termed
SM992, SM1068, SM1086, SM1148, and SM1173, in which the single
tyrosine residues at positions 992, 1068, 1086, 1148, and 1173 were
replaced by phenylalanine, were constructed and subcloned into vec-
tor pRc/CMV as previously described [20]. Additional EGFR mu-
tants, QM992 and F5, in which four tyrosine residues other than
tyrosine 992 and the ¢ve tyrosine residues described above were re-
0014-5793 / 03 / $22.00 J 2003 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
doi:10.1016/S0014-5793(03)00013-9
*Corresponding author. Fax: (81)-3-3823 5284.
E-mail address: ykanaho@rinshoken.or.jp (Y. Kanaho).
Abbreviations: ARF, ADP-ribosylation factor; CHO, Chinese ham-
ster ovary; DAG, diacylglycerol; EGF, epidermal growth factor;
EGFR, EGF receptor; ERK, extracellular signal-regulated kinase;
HA, hemagglutinin; PI(4,5)P2, phosphatidylinositol 4,5-bisphosphate;
PI(4)P, phosphatidylinositol 4-phosphate; PKC, protein kinase C;
PLCQ1, phospholipase CQ1; SH2, Src homology domain 2; TPA,
12-O-tetradecanoylphorbol 13-acetate
FEBS 26942 18-2-03
FEBS 26942 FEBS Letters 536 (2003) 71^76
placed by phenylalanine, were similarly prepared. cDNA for the myc-
tagged dominant negative PLCQ1 fragment, designated PLC-Z, which
consists of SH2 and SH3 domains (amino acids 517^901) of PLCQ1
[21], was subcloned into the pcDNA3-myc vector, a generous gift of
Dr. K. Nakayama. pEF-BOS-Rac1G12V and pEF-BOS-Rac1T17N
were generous gifts of Dr. K. Kaibuchi. Mouse monoclonal anti-
EGFR antibodies for Western blotting (6F1) and immuno£uorescence
(R1), both of which detect WT-EGFR and its mutants used in this
study, were purchased from MBL and Santa Cruz, respectively. Rab-
bit polyclonal anti-PLCQ1 antibody was a generous gift of Dr. C.H.
Heldin. Anti-phospho extracellular signal-regulated kinase (ERK),
anti-ERK, and mouse monoclonal and rabbit polyclonal anti-myc
antibodies (9E10 and A-14, respectively) were obtained from Santa
Cruz. Rat monoclonal anti-hemagglutinin (HA) (3F10) and mouse
monoclonal anti-Rac1 antibodies were from Boehringer Mannheim
and Transduction Laboratories, respectively.
2.2. Cell culture, transfection of plasmids and preparation of
stable cell clone
Chinese hamster ovary (CHO) cells were maintained in a culture
medium comprising Ham/F-12 nutrient medium (Sigma), 10% fetal
bovine serum (Nissui), 100 U/ml of penicillin and 100 Wg/ml of strep-
tomycin (Gibco BRL). Cells were cultured at 8.0U104 cells/ml on
glass coverslips in 8-well chamber plate (Nunc) in the same medium
at 37‡C for 30 h, and transfected with 1 Wg/ml of each expression
plasmid DNA in Opti-MEM-I (Gibco BRL) using Lipofectamine
PLUS (Invitrogen). After incubation at 37‡C for 3 h, these cells
were further cultured at 37‡C for 12 h, starved of serum for 24 h,
and then used for experiments unless otherwise noted. In an experi-
ment for Rac1 activation, clones that stably express QM992 were
selected using G418 (Nakarai) after CHO cells were transiently trans-
fected with pRc/CMV-QM992. Stable clones were cultured in the cul-
ture medium described above at 37‡C for 36 h, starved of serum for
36 h, and then used for experiments.
2.3. Immuno£uorescence microscopy
Parental control and transfected CHO cells cultured on glass cover-
slips were treated as described in the ¢gure legends, ¢xed, permeabi-
lized, and blocked as previously reported [19]. Cells were then stained
for proteins to be visualized with appropriate antibodies and FITC-
and/or Cy3-labeled secondary antibodies (Jackson ImmunoResearch
Laboratories). F-actin was visualized with rhodamine phalloidin (Mo-
lecular Probes). The immuno£uorescently stained cells were imaged
using Zeiss Axiovert S100 (Plan Neo£uar 40U/0.75 NA) equipped
with a Yokogawa confocal scanner unit CSU21.
2.4. Western blotting
Western blotting analysis was performed as described previously
Fig. 1. Induction of EGF-dependent ERK activation and membrane ru¥e formation by expression of WT-EGFR in CHO cells. Parental con-
trol and WT-EGFR-expressing cells were stimulated with 30 ng/ml of EGF at 37‡C. After the indicated times of EGF stimulation, phosphory-
lation of ERK1/2 (pERK1/2), the ERK protein, and the expression level of WT-EGFR were detected by Western blotting probed with the
anti-phospho ERK, anti-ERK, and anti-EGFR (6F1) antibodies, respectively (A). Cells transiently expressing WT-EGFR were also stimulated
without or with 30 ng/ml of EGF at 37‡C for 5 min, and stained for EGFR with the R1 antibody and for F-actin (B). Arrows in B indicate
the membrane ru¥es where WT-EGFR was colocalized with F-actin. Scale bars, 10 Wm.
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Fig. 2. Requirement of autophosphorylation of EGFR at tyrosine 992 for EGF-induced membrane ru¥e formation. WT-EGFR and its mu-
tants, in which phenylalanine (F) was substituted for tyrosine (Y), are schematically illustrated (A). These EGFRs were transiently expressed in
CHO cells as described in Section 2, and their expression levels were determined by Western blotting probed with the anti-EGFR (6F1) anti-
body (B). Cells expressing WT-EGFR and mutated EGFRs were stimulated with EGF and stained for EGFRs and F-actin as described in
Fig. 1B (C,D). Arrows in C and D indicate transfected cells and the membrane ru¥es where EGFRs and F-actin were colocalized, respectively.
Scale bars, 10 Wm.
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[22]. Brie£y, proteins in cell lysates were separated by SDS^PAGE
and transferred to polyvinylidene di£uoride membranes. The mem-
branes were incubated with antibodies speci¢c for each protein to
be detected, and the reactive proteins were visualized by an ECL
system (Amersham Pharmacia Biotech).
2.5. Assay of Rac1 activity
After CHO cells stably expressing QM992 were treated as described
in the legend to Fig. 4C and lysed with lysis bu¡er consisting of 50
mM Tris, pH 7.5, 100 mM NaCl, 1% NP-40, 10 mM MgCl2, 10%
glycerol, 1 mM dithiothreitol, 10 mg/ml aprotinin and 1 mM phenyl-
methylsulfonyl £uoride, activated Rac1 was precipitated with GST-
CRIB and detected with the anti-Rac1 antibody as previously re-
ported [23].
3. Results and discussion
CHO cells are very useful mammalian cells to investigate
the functional domain of EGFR by means of techniques of
molecular biology with EGFR mutants since they are devoid
of endogenous EGFR. In this study, therefore, we employed
these cells to investigate whether autophosphorylation of
EGFR at speci¢c tyrosine residues is required for EGF-in-
duced membrane ru¥e formation. When CHO cells transi-
ently expressing WT-EGFR were stimulated with EGF,
ERK1/2, which are normally activated through the autophos-
phorylated tyrosine 1068 of EGFR [15^17], were signi¢cantly
activated as detected by their phosphorylation, while parental
control cells did not respond to EGF (Fig. 1A), demonstrat-
ing that expressed EGFR is activated and autophosphorylated
in an EGF-dependent manner. Similarly, EGF-dependent
membrane ru¥e formation was observed in CHO cells tran-
siently expressing WT-EGFR, but not in parental control cells
(Fig. 1B). Thus, CHO cells are useful to investigate the func-
tional tyrosine residue(s) of EGFR for EGF-dependent mem-
brane ru¥e formation.
It has been reported that ¢ve major tyrosine residues at
positions 992, 1068, 1086, 1148 and 1173 in the cytoplasmic
region of EGFR are autophosphorylated when EGFR is ac-
tivated by EGF stimulation [8^11]. To examine the require-
ment of EGFR autophosphorylation for EGF-induced mem-
brane ru¥e formation and to identify its site, various EGFR
mutants illustrated in Fig. 2A, in which phenylalanine was
substituted for tyrosine, were constructed and expressed in
CHO cells. Expression levels of EGFR mutants were compa-
rable to that of WT-EGFR (Fig. 2B). Although cells express-
ing WT-EGFR, but not surrounding non-transfected control
cells, triggered EGF-induced membrane ru¥e formation (Fig.
Fig. 3. Involvement of PLCQ1 in membrane ru¥e formation mediated through the autophosphorylated tyrosine 992 of EGFR. CHO cells tran-
siently expressing WT-EGFR or QM992 were stimulated with EGF as in Fig. 1B, and stained for expressed EGFRs and endogenous PLCQ1
with R1 and rabbit polyclonal anti-PLCQ1 antibodies, respectively (A). CHO cells expressing WT-EGFR or QM992 were treated with 0.5%
DMSO (U731223) or 5 WM U73122 in 0.5% DMSO (U73122+) at 37‡C for 15 min, stimulated with EGF and then stained for EGFRs as in
Fig. 1B (B). CHO cells coexpressing myc-tagged PLC-Z with WT-EGFR or QM992 were stimulated with EGF as in Fig. 1B and stained for
EGFRs with the R1 antibody and for PLC-Z with the polyclonal anti-myc (A-14) antibody (C). Arrows in A indicate the membrane ru¥es
where EGFRs and PLCQ1 were colocalized. Scale bars, 10 Wm.
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2C), cells expressing F5, the EGFR mutant in which ¢ve ty-
rosine residues of major autophosphorylation sites were mu-
tated, as well as surrounding non-transfected control cells,
failed to do so (Fig. 2C), indicating that autophosphorylation
of tyrosine residue(s) in EGFR is essential for this cellular
response. In this experiment, about 70% of cells transfected
with WT-EGFR responded to EGF stimulation, and more
than 90% of cells transfected with F5 failed to do so (data
not shown). Interestingly, cells expressing SM992, in which
tyrosine 992 was mutated, did not induce membrane ru¥es
in response to EGF stimulation, whereas cells expressing the
other four EGF mutants, SM1068, SM1086, SM1148 and
SM1173, produced membrane ru¥es (Fig. 2D). These results
suggest that autophosphorylation of EGFR at tyrosine 992 is
indispensable for EGF-induced membrane ru¥e formation.
Consistent with this idea, cells expressing QM992, in which
four tyrosine residues other than tyrosine 992 were mutated,
responded to EGF, resulting in the formation of membrane
ru¥es (Fig. 2D). Again, 65^80% of cells transfected with
SM1068, SM1086, SM1173 and QM992 responded to EGF
stimulation, and 90^95% of cells transfected with SM992 did
not (data not shown). Furthermore, the EGF-induced mem-
brane ru¥es in these cells were inhibited by the speci¢c EGFR
kinase inhibitor AG1478 (data not shown), supporting the
notion described above.
It has been reported that PLCQ1 binds to the autophos-
phorylated tyrosine 992 of EGFR through its SH2 domain
[17,24], is activated by EGFR [25], and colocalizes with
EGFR at membrane ru¥es [26]. These reports led us to spec-
ulate that PLCQ1 is an EGFR-proximal signaling molecule
involved in the signaling pathway of membrane ru¥e forma-
tion. In support of this hypothesis, endogenous PLCQ1 colo-
calized with transiently expressed WT-EGFR and QM992 at
membrane ru¥es formed by EGF stimulation (Fig. 3A), and
membrane ru¥e formation in these cells was inhibited by the
speci¢c inhibitor of PLC, U73122 [27,28] (Fig. 3B). Further-
more, it was found that the dominant negative PLCQ1 frag-
ment, PLC-Z [21], prevented EGF-induced membrane ru¥e
formation in cells expressing WT-EGFR and QM992 (Fig.
3C). These results, taken together, provide evidence that
PLCQ1 functions as a downstream signaling molecule of the
autophosphorylated tyrosine 992 of EGFR in the signaling
pathway of EGF-induced membrane ru¥e formation.
It is well known that the small GTP-binding protein Rac1 is
the key molecule in EGF-induced membrane ru¥e formation
[18]. A question raised here is the relationship between PLCQ1
Fig. 4. PLCQ1 functions as an upstream signaling molecule of Rac1 in the signaling pathway of EGF-induced membrane ru¥e formation. The
dominant negative Rac1T17N tagged with HA was coexpressed with WT-EGFR or QM992, and cells were stimulated with EGF as in Fig. 1B
and stained for EGFR with the R1 antibody and for HA-tagged Rac1T17N with the anti-HA antibody (A). The constitutively active mutant
Rac1G12V tagged with HA was coexpressed with myc-tagged PLC-Z in CHO cells, and cells were stained for HA-tagged Rac1G12V and myc-
tagged PLC-Z with anti-HA and anti-myc antibodies, respectively (B). Cells stably expressing QM992 were treated without or with 20 WM
U73122 at 37‡C for 15 min, stimulated without or with 30 ng/ml EGF at 37‡C for 1 min, and then the active form of Rac1 was assessed as de-
scribed in Section 2.
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and Rac1 in the signaling pathway of membrane ru¥e for-
mation. To address this issue, we employed dominant negative
and constitutively active Rac1 mutants, Rac1T17N and
Rac1G12V, respectively. Rac1T17N inhibited EGF-induced
membrane ru¥e formation in cells expressing WT-EGFR
and QM992, whereas PLC-Z failed to inhibit Rac1G12V-in-
duced membrane ru¥e formation, which was more intensive
than that induced by EGF stimulation (Fig. 4A,B). Further-
more, it was found that the activation of Rac1 by EGF stim-
ulation of cells stably expressing QM992 was inhibited by
U73122. These results, taken together, provide evidence that
PLCQ1 is the signaling molecule upstream of Rac1 in the
signaling pathway of EGF-induced membrane ru¥e forma-
tion.
Thus, we demonstrated that phosphotyrosine of EGFR at
position 992 is indispensable for EGF-induced membrane ruf-
£e formation and that PLCQ1 is the EGFR-proximal docking
enzyme linking to Rac1 in this cellular response. Although, at
present, the molecular mechanism by which PLCQ1 transduces
the signal to Rac1 remains to be clari¢ed, Rac1 activation
may be mediated by protein kinase C (PKC) activation by
the PLCQ1 product diacylglycerol (DAG). This idea is consis-
tent with the recent report by Grimmer et al. that the phorbol
ester 12-O-tetradecanoylphorbol 13-acetate (TPA), a potent
activator of PKC, activates Rac1 and the TPA-induced mem-
brane ru¥es are inhibited by Rac1T17N in A431 cells [29].
We have recently reported that production of PI(4,5)P2 by
the action of PI(4)P 5-kinase is important for EGF-induced
membrane ru¥e formation, probably to reorganize the actin
cytoskeleton at the cell periphery [19]. In the present study,
the results provide evidence that activation of PLCQ1 that
hydrolyzes PI(4,5)P2 is also required for EGF-induced mem-
brane ru¥e formation. As was shown in Fig. 4, activation of
PLCQ1 appears to be required for Rac1 activation, probably
through PKC activation by the PLCQ1 product DAG as was
discussed above. On the other hand, PI(4)P 5-kinase seems to
function as a signaling molecule downstream of Rac1. These
¢ndings suggest that a temporary change in PI(4,5)P2 level
triggered by degradation by PLCQ1 and subsequent produc-
tion by PI(4)P 5-kinase at the limited area of the plasma
membrane is important for the signaling pathway of EGF-
dependent membrane ru¥e formation.
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